Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Victoza on metabolic response to exercise in type 2 diabetes
2011-002739-24Phase 4Completed
- Sponsor
- Dr. med. Tina Vilsbøll
- Start
- Aug 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide (Victoza) + physical training with Placebo + physical training (2 arms). Primary endpoint: Change from baseline in HbA1c. Started Aug 2011; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-002739-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002739-24.